Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/6755

TDMS Study 05188-06 Pathology Tables

NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96
Route: SKIN APPLICATION                                                                                           Time: 05:02:39




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  1300-72-7

       Lock Date:  07/28/93

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All




































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      7           10            9            8                                     
    Moribund Sacrifice                                12            7            9            6                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                31           32           32           36                                     
  Missing                                                           1                                                               

  Animals Examined Microscopically                    50           49           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (16)         (18)         (50)                                   
      Inflammation                                                  1 (6%)                                                          
   Intestine Small, Duodenum                          (50)         (17)         (18)         (50)                                   
      Inflammation                                     1 (2%)                                                                       
   Intestine Small, Ileum                             (50)         (17)         (18)         (50)                                   
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
   Liver                                              (50)         (49)         (50)         (50)                                   
      Angiectasis                                      1 (2%)                                                                       
      Basophilic Focus                                              3 (6%)       2 (4%)       1 (2%)                                
      Clear Cell Focus                                              1 (2%)                                                          
      Eosinophilic Focus                              14 (28%)     11 (22%)     11 (22%)     10 (20%)                               
      Hematopoietic Cell Proliferation                 2 (4%)       2 (4%)       1 (2%)       1 (2%)                                
      Infarct                                                                                 1 (2%)                                
      Inflammation, Chronic Active                    22 (44%)     28 (57%)     24 (48%)     21 (42%)                               
      Mixed Cell Focus                                10 (20%)      3 (6%)       1 (2%)       7 (14%)                               
      Necrosis                                         3 (6%)       4 (8%)       9 (18%)      3 (6%)                                
      Pigmentation, Hemosiderin                        1 (2%)                                 1 (2%)                                
      Bile Duct, Cyst                                  2 (4%)                                                                       
      Bile Duct, Hyperplasia                           4 (8%)       2 (4%)       4 (8%)       2 (4%)                                
      Serosa, Necrosis                                                           1 (2%)                                             
   Mesentery                                          (7)          (6)          (5)          (12)                                   
      Inflammation                                     1 (14%)                   1 (20%)                                            
      Fat, Necrosis                                    3 (43%)      2 (33%)                   7 (58%)                               
   Pancreas                                           (50)         (17)         (18)         (50)                                   
      Atrophy                                          3 (6%)                    1 (6%)       6 (12%)                               
      Cytoplasmic Alteration                           1 (2%)                                 1 (2%)                                
      Inflammation                                     1 (2%)                                                                       
      Necrosis                                                                                1 (2%)                                
      Duct, Cyst                                       2 (4%)       2 (12%)      1 (6%)       5 (10%)                               
   Salivary Glands                                    (50)         (17)         (18)         (50)                                   
      Atrophy                                          1 (2%)                                 1 (2%)                                
      Fibrosis                                                                                1 (2%)                                
   Stomach, Forestomach                               (50)         (17)         (18)         (50)                                   

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    2                                                              
NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Erosion                                                                    1 (6%)                                             
      Hyperplasia, Focal                               1 (2%)       1 (6%)                    3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (17)         (18)         (50)                                   
      Aorta, Inflammation, Chronic Active                                                     1 (2%)                                
   Heart                                              (50)         (17)         (18)         (50)                                   
      Degeneration                                                  2 (12%)                                                         
      Mineralization                                   5 (10%)                                1 (2%)                                
      Atrium, Thrombosis                                                                      1 (2%)                                
      Epicardium, Inflammation, Suppurative                                      1 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (17)         (18)         (50)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)                                                                       
      Degeneration                                                                            1 (2%)                                
      Hyperplasia                                                                1 (6%)       2 (4%)                                
      Capsule, Hyperplasia, Adenomatous                1 (2%)                                                                       
   Adrenal Medulla                                    (50)         (17)         (18)         (48)                                   
      Hyperplasia                                      3 (6%)                    1 (6%)       3 (6%)                                
   Islets, Pancreatic                                 (50)         (17)         (18)         (50)                                   
      Hyperplasia                                      7 (14%)      1 (6%)       2 (11%)      4 (8%)                                
   Pituitary Gland                                    (50)         (17)         (18)         (49)                                   
      Cyst                                             1 (2%)                                                                       
      Pars Distalis, Hyperplasia                      25 (50%)      6 (35%)     11 (61%)     26 (53%)                               
   Thyroid Gland                                      (50)         (48)         (50)         (50)                                   
      Inflammation                                                               1 (2%)                                             
      Follicle, Cyst                                   1 (2%)                                                                       
      Follicular Cell, Hyperplasia                    26 (52%)     19 (40%)     19 (38%)     25 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (50)         (17)         (18)         (49)                                   
      Cyst                                            10 (20%)                   2 (11%)     13 (27%)                               
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Metaplasia                                       1 (2%)                                                                       

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    3                                                              
NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Thrombosis                                                                 1 (6%)                                             
   Oviduct                                                                                   (1)                                    
      Inflammation, Chronic                                                                   1 (100%)                              
   Uterus                                             (50)         (17)         (18)         (50)                                   
      Hemorrhage                                                                 1 (6%)                                             
      Hyperplasia, Cystic                             21 (42%)      2 (12%)      4 (22%)     22 (44%)                               
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Lymphatic, Angiectasis                           1 (2%)                                                                       
      Lymphatic, Cyst                                  1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (17)         (18)         (50)                                   
      Hyperplasia                                     12 (24%)      1 (6%)       4 (22%)     11 (22%)                               
      Myelofibrosis                                    1 (2%)                                 4 (8%)                                
   Lymph Node                                         (7)          (3)          (6)          (6)                                    
      Mediastinal, Hyperplasia, Lymphoid               1 (14%)                                                                      
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                                          1 (17%)                               
   Lymph Node, Mesenteric                             (48)         (17)         (17)         (50)                                   
      Angiectasis                                      1 (2%)                                 2 (4%)                                
      Hematopoietic Cell Proliferation                 2 (4%)                                                                       
      Hemorrhage                                                    1 (6%)                                                          
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)                                                                       
   Spleen                                             (50)         (17)         (18)         (50)                                   
      Angiectasis                                                                             1 (2%)                                
      Hematopoietic Cell Proliferation                19 (38%)      8 (47%)     12 (67%)     11 (22%)                               
   Thymus                                             (38)         (16)         (16)         (44)                                   
      Atrophy                                          5 (13%)      7 (44%)      4 (25%)      4 (9%)                                
      Cyst                                                                       1 (6%)                                             
      Hyperplasia, Lymphoid                            2 (5%)       1 (6%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (17)         (16)         (50)                                   
      Hyperplasia                                      5 (10%)      1 (6%)       3 (19%)      6 (12%)                               
   Skin                                               (50)         (49)         (50)         (50)                                   
      Epidermis, Skin, Site of Application, Exudate    1 (2%)       4 (8%)       4 (8%)       1 (2%)                                
      Epidermis, Skin, Site of Application,                                                                                         
          Hyperplasia                                  4 (8%)       1 (2%)       4 (8%)       4 (8%)                                
      Epidermis, Skin, Site of Application, Ulcer                   1 (2%)       1 (2%)       1 (2%)                                
      Skin, Site of Application, Inflammation,                                                                                      
           Chronic                                     4 (8%)       1 (2%)       1 (2%)       1 (2%)                                
      Skin, Site of Application, Parakeratosis                                   1 (2%)                                             

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    4                                                              
NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Subcutaneous Tissue, Edema                                    1 (2%)                                                          
      Subcutaneous Tissue, Skin, Site of                                                                                            
          Application, Inflammation, Chronic Active                 1 (2%)       2 (4%)                                             
      Subcutaneous Tissue, Skin, Site of                                                                                            
          Application, Inflammation, Suppurative       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (17)         (18)         (50)                                   
      Inflammation                                                               1 (6%)                                             
      Neuron, Necrosis                                 2 (4%)       1 (6%)       4 (22%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (18)         (18)         (50)                                   
      Hemorrhage                                       1 (2%)                                 1 (2%)                                
      Hyperplasia, Lymphoid                                                                   1 (2%)                                
      Inflammation                                     1 (2%)                                                                       
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Thrombosis                                                                 1 (6%)                                             
      Alveolar Epithelium, Hyperplasia                 2 (4%)                                 2 (4%)                                
      Bronchiole, Hyperplasia                          1 (2%)                                 1 (2%)                                
   Nose                                               (50)         (17)         (18)         (50)                                   
      Inflammation, Suppurative                        1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (2)                                                              
      Degeneration                                                  1 (50%)                                                         
      Cornea, Inflammation                             1 (100%)                                                                     
   Harderian Gland                                    (5)          (2)          (1)          (3)                                    
      Hyperplasia                                      1 (20%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    5                                                              
NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (17)         (18)         (50)                                   
      Hydronephrosis                                                                          1 (2%)                                
      Infarct                                                                    1 (6%)                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mineralization                                   1 (2%)                                                                       
      Nephropathy                                     22 (44%)      1 (6%)       6 (33%)     17 (34%)                               
      Pigmentation                                     2 (4%)                                                                       
      Artery, Inflammation, Chronic Active                                       1 (6%)                                             
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    6                                                              
NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                     11           10            3            9                                     
    Moribund Sacrifice                                 7            3            8            6                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                32           37           39           35                                     

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Small, Duodenum                          (50)         (12)         (10)         (50)                                   
      Necrosis                                         1 (2%)                                                                       
      Ulcer                                            1 (2%)                                                                       
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      2 (4%)       2 (4%)                    1 (2%)                                
      Basophilic Focus                                 2 (4%)       6 (12%)      3 (6%)       4 (8%)                                
      Clear Cell Focus                                 4 (8%)       3 (6%)       3 (6%)       8 (16%)                               
      Eosinophilic Focus                              13 (26%)     11 (22%)     12 (24%)      9 (18%)                               
      Hematopoietic Cell Proliferation                 3 (6%)                    1 (2%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Infarct                                                                    1 (2%)                                             
      Inflammation, Chronic Active                    46 (92%)     44 (88%)     41 (82%)     43 (86%)                               
      Mixed Cell Focus                                 3 (6%)       4 (8%)       5 (10%)      7 (14%)                               
      Necrosis                                         8 (16%)      5 (10%)      2 (4%)       8 (16%)                               
      Thrombosis                                       1 (2%)                    1 (2%)                                             
      Vacuolization Cytoplasmic                                     2 (4%)       1 (2%)       1 (2%)                                
      Bile Duct, Hyperplasia                          43 (86%)     41 (82%)     36 (72%)     37 (74%)                               
      Kupffer Cell, Pigmentation                       1 (2%)                                                                       
   Mesentery                                          (5)                                    (4)                                    
      Hemorrhage                                                                              1 (25%)                               
      Artery, Inflammation, Chronic Active             1 (20%)                                1 (25%)                               
      Fat, Inflammation                                1 (20%)                                                                      
      Vein, Thrombosis                                 1 (20%)                                1 (25%)                               
   Pancreas                                           (50)         (13)         (11)         (50)                                   
      Atrophy                                          3 (6%)                    1 (9%)       4 (8%)                                
      Cytoplasmic Alteration                           4 (8%)                                                                       
      Necrosis                                         1 (2%)                    1 (9%)                                             
      Artery, Inflammation, Chronic Active             2 (4%)                                                                       
   Salivary Glands                                    (50)         (13)         (11)         (50)                                   
      Atrophy                                                                                 1 (2%)                                
      Necrosis                                                                   1 (9%)                                             
   Stomach, Forestomach                               (50)         (13)         (11)         (50)                                   
      Cyst                                             1 (2%)                                                                       
      Hyperplasia, Focal                               1 (2%)                    1 (9%)       2 (4%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    7                                                              
NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Ulcer                                            2 (4%)                                                                       
   Stomach, Glandular                                 (50)         (13)         (11)         (50)                                   
      Erosion                                                                                 1 (2%)                                
      Mineralization                                                                          1 (2%)                                
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (13)         (11)         (50)                                   
      Aorta, Inflammation, Chronic Active              1 (2%)                    1 (9%)       1 (2%)                                
   Heart                                              (50)         (13)         (11)         (50)                                   
      Degeneration                                     2 (4%)       1 (8%)       1 (9%)       1 (2%)                                
      Mineralization                                   1 (2%)                                 2 (4%)                                
      Artery, Inflammation, Chronic Active             1 (2%)                                 1 (2%)                                
      Atrium, Thrombosis                               1 (2%)       1 (8%)       1 (9%)       1 (2%)                                
      Ventricle, Thrombosis                                         1 (8%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (12)         (11)         (50)                                   
      Accessory Adrenal Cortical Nodule                2 (4%)                    1 (9%)       1 (2%)                                
      Degeneration, Cystic                                                                    1 (2%)                                
      Hemorrhage                                                                              1 (2%)                                
      Hyperplasia                                     11 (22%)      1 (8%)       1 (9%)      19 (38%)                               
      Inflammation, Chronic Active                                                            1 (2%)                                
      Capsule, Hyperplasia, Adenomatous                                                       4 (8%)                                
   Adrenal Medulla                                    (50)         (12)         (11)         (50)                                   
      Hyperplasia                                      2 (4%)       2 (17%)      1 (9%)       1 (2%)                                
   Islets, Pancreatic                                 (50)         (12)         (11)         (50)                                   
      Hyperplasia                                      9 (18%)                   2 (18%)      9 (18%)                               
   Parathyroid Gland                                  (46)         (9)          (7)          (42)                                   
      Cyst                                                                                    1 (2%)                                
   Pituitary Gland                                    (49)         (12)         (10)         (50)                                   
      Cyst                                             2 (4%)                                 2 (4%)                                
      Pars Distalis, Hyperplasia                       2 (4%)                                 2 (4%)                                
      Pars Intermedia, Hyperplasia                                                            2 (4%)                                
   Thyroid Gland                                      (50)         (13)         (11)         (50)                                   
      Follicular Cell, Hyperplasia                     6 (12%)      2 (15%)                  10 (20%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    8                                                              
NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (13)         (11)         (50)                                   
      Granuloma Sperm                                  2 (4%)                                 2 (4%)                                
      Artery, Inflammation, Chronic Active                                       1 (9%)       1 (2%)                                
   Preputial Gland                                    (50)         (13)         (10)         (49)                                   
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Duct, Cyst                                       7 (14%)      1 (8%)       4 (40%)      6 (12%)                               
   Prostate                                           (50)         (13)         (11)         (50)                                   
      Degeneration                                                               1 (9%)                                             
      Artery, Inflammation, Chronic Active                                       1 (9%)       1 (2%)                                
   Seminal Vesicle                                    (50)         (13)         (11)         (50)                                   
      Degeneration                                                               1 (9%)                                             
   Testes                                             (50)         (13)         (11)         (50)                                   
      Atrophy                                                                                 2 (4%)                                
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (13)         (11)         (50)                                   
      Angiectasis                                      1 (2%)                                                                       
      Hyperplasia                                     17 (34%)      3 (23%)      4 (36%)     23 (46%)                               
      Infiltration Cellular, Mast Cell                 1 (2%)                                                                       
      Infiltration Cellular, Plasma Cell               1 (2%)                                                                       
      Myelofibrosis                                    1 (2%)                                                                       
      Thrombosis                                                                              1 (2%)                                
   Lymph Node                                         (3)          (2)          (2)          (3)                                    
      Mediastinal, Angiectasis                                                                1 (33%)                               
      Mediastinal, Hematopoietic Cell Proliferation    1 (33%)                                                                      
   Lymph Node, Mesenteric                             (50)         (9)          (10)         (47)                                   
      Angiectasis                                      1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 1 (2%)                    1 (10%)                                            
      Hyperplasia, Histiocytic                                                                1 (2%)                                
      Hyperplasia, Lymphoid                            1 (2%)                    1 (10%)                                            
      Hyperplasia, Plasma Cell                                                                1 (2%)                                
   Spleen                                             (50)         (13)         (12)         (49)                                   
      Hematopoietic Cell Proliferation                27 (54%)      8 (62%)      8 (67%)     25 (51%)                               
      Lymphoid Follicle, Depletion Cellular                                                   1 (2%)                                
      Lymphoid Follicle, Hyperplasia                   1 (2%)                                                                       
   Thymus                                             (37)         (11)         (6)          (34)                                   
      Atrophy                                          9 (24%)      5 (45%)      2 (33%)      6 (18%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    9                                                              
NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (50)                                   
      Epidermis, Skin, Site of Application, Exudate                 1 (2%)       1 (2%)       1 (2%)                                
      Epidermis, Skin, Site of Application,                                                                                         
          Hyperkeratosis                                                         1 (2%)                                             
      Epidermis, Skin, Site of Application,                                                                                         
          Hyperplasia                                  1 (2%)                    4 (8%)       5 (10%)                               
      Epidermis, Skin, Site of Application, Ulcer                                             1 (2%)                                
      Subcutaneous Tissue, Edema                       1 (2%)                    1 (2%)       1 (2%)                                
      Subcutaneous Tissue, Inflammation,                                                                                            
          Suppurative                                                            1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (13)         (11)         (50)                                   
      Inflammation                                                               1 (9%)                                             
      Artery, Inflammation, Chronic Active                                       1 (9%)                                             
      Corpus Callosum, Degeneration                                                           1 (2%)                                
      Neuron, Necrosis                                              1 (8%)       1 (9%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (16)         (15)         (50)                                   
      Inflammation                                                               1 (7%)                                             
      Pigmentation, Hemosiderin                                                  1 (7%)                                             
      Thrombosis                                                                 1 (7%)                                             
      Alveolar Epithelium, Hyperplasia                              2 (13%)      1 (7%)       2 (4%)                                
      Mediastinum, Angiectasis                         1 (2%)                                                                       
   Nose                                               (50)         (13)         (11)         (50)                                   
      Inflammation, Suppurative                                                               1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                                                       (2)                                    
      Inflammation                                                                            1 (50%)                               
   Harderian Gland                                    (2)                       (1)          (3)                                    
      Hyperplasia                                      1 (50%)                                1 (33%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   10                                                              
NTP Experiment-Test: 05188-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       SODIUM XYLENESULFONATE                                  Date: 04/04/96  
Route: SKIN APPLICATION                                                                                           Time: 05:02:39  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      182          364          727                                       
                                                                MG/KG        MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (13)         (11)         (50)                                   
      Cyst                                             5 (10%)                                8 (16%)                               
      Glomerulosclerosis                               2 (4%)       1 (8%)                    4 (8%)                                
      Hydronephrosis                                                                          1 (2%)                                
      Infarct                                          1 (2%)                                 1 (2%)                                
      Mineralization                                                                          4 (8%)                                
      Nephropathy                                     43 (86%)     10 (77%)      8 (73%)     43 (86%)                               
      Pigmentation, Hemosiderin                        1 (2%)                    1 (9%)       1 (2%)                                
      Artery, Inflammation, Chronic Active                                       1 (9%)       1 (2%)                                
      Glomerulus, Infarct                              1 (2%)                                                                       
      Glomerulus, Thrombosis                                                     1 (9%)                                             
      Renal Tubule, Hyperplasia                                                               1 (2%)                                
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   11                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------